Biomarin Pharmaceutical Inc (BMRN) — Cash Flow Reinvestment Rate
Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Reinvestment Rate of 0.42x as of December 2025, reinvesting $41.36 Million (capex $40.72 Million plus investments $641.00K) from operating cash flow of $99.64 Million. Explore reinvestment intensity of Biomarin Pharmaceutical Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biomarin Pharmaceutical Inc Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Biomarin Pharmaceutical Inc across 12 annual periods. Also explore balance sheet size of Biomarin Pharmaceutical Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year capital reinvestment analysis for Biomarin Pharmaceutical Inc. For live market cap and broader valuation context, see Biomarin Pharmaceutical Inc (BMRN) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | $121.11 Million | $827.99 Million | $103.04 Million | ▼ -64.2% |
| 2024 | 0.41x | $233.91 Million | $572.84 Million | $97.42 Million | ▼ -67.1% |
| 2023 | 1.24x | $197.68 Million | $159.26 Million | $96.69 Million | ▲ +54.9% |
| 2022 | 0.80x | $140.99 Million | $175.90 Million | $120.96 Million | ▼ -49.7% |
| 2021 | 1.59x | $485.54 Million | $304.54 Million | $119.22 Million | ▼ -16.9% |
| 2020 | 1.92x | $163.69 Million | $85.36 Million | $137.52 Million | ▼ -63.5% |
| 2019 | 5.25x | $253.21 Million | $48.26 Million | $145.03 Million | ▼ -78.9% |
| 2018 | 24.92x | $503.60 Million | $20.21 Million | $144.62 Million | ▲ +124.3% |
| 2012 | 11.11x | $195.65 Million | $17.61 Million | $44.57 Million | ▼ -4.8% |
| 2011 | 11.67x | $218.88 Million | $18.75 Million | $154.22 Million | ▲ +219.9% |
| 2010 | 3.65x | $68.39 Million | $18.75 Million | $49.46 Million | ▲ +256.4% |
| 2009 | 1.02x | $89.80 Million | $87.73 Million | $89.80 Million | — |